PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

the chances of becoming the next CSL are unfortunately unlikely...

  1. 868 Posts.
    lightbulb Created with Sketch. 73
    the chances of becoming the next CSL are unfortunately unlikely as there it a strong chance that we go into partnership with a big pharma. who will provide the required funding going forward.
    I think that the partnership is a good result which will catapult the share price to a much higher level.
    I also think that Management is holding out as long as possible so to get the best deal for PAR. Good results from the US footballers will get us close to a partnership deal with big phara.
    I think that the timing for a partnership is about right at this point of the journey.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $101.4M
Open High Low Value Volume
29.0¢ 29.3¢ 28.0¢ $57.32K 198.9K

Buyers (Bids)

No. Vol. Price($)
1 12454 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 4443 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.